Clinical Trials Insight: 700041500
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2009
At a glance
- Drugs Anti-CD20 monoclonal antibody (Primary)
- Indications Lymphoid leukaemia
- Focus Adverse reactions
- Sponsors LFB
- 12 Feb 2009 New trial record.
- 10 Feb 2009 Dosing has commenced according to an LFB media release.